Subscribe to RSS - Dan Greenleaf

Dan Greenleaf

BioScrip revenues are down, but core product mix is up


DENVER – BioScrip’s net revenues decreased 6.2% in the second quarter of 2017, but CEO Dan Greenleaf said in an earnings call the company was hitting targets.

BioScrip earnings ‘in line’ with expectations


DENVER – BioScrip reported net revenues of $217.8 million for the first quarter of 2017, reflecting a core revenue mix of 72% compared to 60% during the same quarter in 2016. Net loss was $19 million and adjusted EBITD was 5.2 million.

'Clear mission' says Greenleaf


With one full financial quarter under his belt, BioScrip President and CEO Dan Greenleaf says the company is reinvigorated and on track to right itself.

CORE is key to BioScrip reversal


DENVER – BioScrip has pushed closer to its goal of having its core home infusion business make up 85% of its overall revenue, said company executives on a recent earnings call.

Greenleaf: 'Home infusion is a valuable option'


In his six years in the home infusion business, Dan Greenleaf has seen his share of challenges. Still, the new CEO of Home Solutions says it’s an exciting place to be. He spoke with HME News recently about home infusion’s role in the “medical neighborhood.”